Sanjeevani Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 1.25 Cr
- Company Age 21 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 15.40 Cr
- Revenue Growth -80.99%
- Profit Growth -93.06%
- Ebitda 9.57%
- Net Worth 0.91%
- Total Assets -79.06%
About Sanjeevani Bio-Tech
Sanjeevani Bio-Tech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 May 2003 and has a history of 21 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company has closed loans amounting to ₹15.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dinesh Jain, Bikash Jain, and Amit Jain serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24234GJ2003PTC042388
-
Company No.
042388
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 May 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Sanjeevani Bio-Tech?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dinesh Jain | Director | 12-Jul-2003 | Current |
Bikash Jain | Additional Director | 01-Dec-2007 | Current |
Amit Jain | Additional Director | 01-Dec-2007 | Current |
Financial Performance of Sanjeevani Bio-Tech.
Sanjeevani Bio-Tech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 80.99% decrease. The company also saw a substantial fall in profitability, with a 93.06% decrease in profit. The company's net worth moved up by a moderate rise of 0.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sanjeevani Bio-Tech?
In 2021, Sanjeevani Bio-Tech had a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹15.40 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 15.40 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
10 Oct 2007 | State Bank Of India | ₹7.25 Cr | Satisfied |
01 Aug 2006 | State Bank Of India | ₹9.00 M | Satisfied |
05 Jul 2006 | State Bank Of India | ₹7.25 Cr | Satisfied |
How Many Employees Work at Sanjeevani Bio-Tech?
Sanjeevani Bio-Tech has a workforce of 21 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanjeevani Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjeevani Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.